Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
<p>Abstract</p> <p>Background</p> <p>Liver transplantation is the most effective therapy for cirrhosis-associated hepatocellular carcinoma (HCC) but its utility is limited by post-transplant tumor recurrence. Use of the Milan, size-based criteria, has reduced recurrence...
Main Authors: | Zeng Zhen, Ren Jinyu, O’Neil Maura, Zhao Jie, Bridges Brian, Cox Josiah, Abdulkarim Bashar, Schmitt Timothy M, Kumer Sean C, Weinman Steven A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/584 |
Similar Items
-
An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells
by: Daniel A. Vallera, et al.
Published: (2013-01-01) -
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
by: Anna Torres, et al.
Published: (2019-04-01) -
Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
by: Hwa-Yong Lee, et al.
Published: (2020-09-01) -
Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets
by: Lorena Vázquez-Iglesias, et al.
Published: (2019-07-01) -
Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)